Advertisement · 728 × 90

Posts by Raymond Hsu

Post image

Proud to introduce our incoming class of UCSF Nephrology fellows. What a phenomenal match!!

4 months ago 6 1 0 0
JAMA infographic: A study on dialysis strategies for AKI patients. Population: 148 men, 72 women, mean age 56. Intervention: 109 conservative, 109 conventional dialysis. Findings: Conservative 64% recovery vs conventional 50%.

JAMA infographic: A study on dialysis strategies for AKI patients. Population: 148 men, 72 women, mean age 56. Intervention: 109 conservative, 109 conventional dialysis. Findings: Conservative 64% recovery vs conventional 50%.

In stable AKI patients, indication-based dialysis enabled faster liberation from dialysis and reduced health care resource use compared to conventional thrice-weekly treatment.

#KidneyWK @asnkidney.bsky.social

ja.ma/47GXUgm

5 months ago 7 2 0 0
Visual abstract

Visual abstract

Trials coming out already!

jamanetwork.com/journals/jam...

Rituximab better than placebo in FRNS/SDNS

Duh.

#KidneyWk #NephSky

5 months ago 22 8 1 0
Post image

“.. Since the pandemic, he has mostly lived on the Big Island of Hawaii, where he has bought up numerous parcels of land. He said that he wasn’t sure how many days he spends each year in San Francisco ..”

@nytimes.com $CRM
www.nytimes.com/2025/10/10/u...

6 months ago 1073 353 166 50
Post image Post image Post image

🎓 Congratulations to our 2025 Nephrology Fellowship Graduates! 🩺

We are proud to send off this exceptional group of nephrologists who are ready to make an impact wherever they go. Here’s to the next chapter in your careers—your patients (and their kidneys) are in great hands.

9 months ago 11 1 1 0
Post image

Celebrating another successful year of our GN club with fellows and faculty @ucsfnephrology.bsky.social

9 months ago 7 0 0 0
Post image

#ASNCJASN welcomes original kidney health-focused artwork submissions for consideration on future covers. Creative, thought-provoking pieces are sought to reflect the impact of kidney health on individuals and communities. Submit your artwork today at www.editorialmanager....

10 months ago 1 1 0 0
Preview
Exploring the Optimal Blood Pressure Target in Advanced CKD Dr. Nozaina Mahmood is a Nephrology fellow at the University of Alabama at Birmingham with clinical and academic interests in chronic kidney disease, health disparities in nephrology, and evidence-…

Good write up of the @drraymondhsu.bsky.social et al BP trial in advanced CKD, on the @ajkd.bsky.social blog: ajkdblog.org/2025/05/28/e...

RCT here: www.ajkd.org/action/consu...

10 months ago 14 4 0 0

This #AAPIHeritageMonth, we’re raising awareness of how lupus impacts the AAPI community and why understanding health disparities is critical to creating change. Learn more: buff.ly/0I73RQ8

11 months ago 2 1 0 0
Post image

The Asian American and Pacific Islander (AAPI) community encompasses diverse cultures and languages. They face a disproportionate burden with #lupus. Lupus-related death rates among Hispanic and Asian women are 4–6 times higher than the general population.

11 months ago 5 2 1 0
Advertisement
Preview
Brown University Surgeon and Professor Are Deported to Lebanon Despite a Judge’s Order (Gift Article) Dr. Rasha Alawieh, a kidney transplant specialist and Brown University professor who had a valid visa, was expelled in apparent defiance of a court order.

The @nytimes.com with @danagoldstein.bsky.social cover the story of Dr Rasha Alawieh being deported despite the Judge’s order (gift link)

(She’s a nephrologist, not a surgeon, but that doesn’t matter here)

www.nytimes.com/2025/03/16/u...

1 year ago 54 26 3 3
Preview
Welcome to #NephMadness 2025 Here it is, the 13th edition of NephMadness!  Whether you’re new to the competition or just want to relive past glories, we have all the info you need for NephMadness 2025: What is NephMadnes…

#NephMadness 2025 is live on the #AJKDBlog: bit.ly/WelcomeNM25

Topics include:
- Resistant Hypertension
- Obesity
- Green House
- Minimal Change Disease
- Disaster Nephrology
- Genetics
- Hemodialysis
- CAR-T for Kidney Disease

Looking forward to the fun and learning with all of you!

1 year ago 18 14 0 3

It is a full fledge assault on medical research. Turning off funding, canceling grants, and disabling the tools we use. It is a complete dismantling of the infrastructure.

1 year ago 60 16 2 0
Preview
NKF Statement on Mass Staff Terminations at HHS

We urge the Administration and Congress to reconsider and roll back these actions immediately so potential cuts can be made in a thoughtful and safer manner. To do otherwise may result in absolute tragedy for the American people.

1 year ago 36 18 0 1

Love this panel. Let the #blueribbonfail roasting begin!

1 year ago 0 0 0 0
Atrasentan for IgA Nephropathy

A Research Summary based on Heerspink HJL et al. | 10.1056/NEJMoa2409415 | Published on October 25, 2024

Atrasentan for IgA Nephropathy A Research Summary based on Heerspink HJL et al. | 10.1056/NEJMoa2409415 | Published on October 25, 2024

In a prespecified interim analysis of a phase 3, randomized, controlled trial, the selective endothelin type A receptor antagonist atrasentan reduced proteinuria in patients with IgA nephropathy, without apparent safety issues. Full ALIGN trial results: nej.md/3NzvISW

#MedSky #Nephrology

1 year ago 20 9 0 0
Preview
Efficacy and Safety of Obinutuzumab in Active Lupus Nephritis | NEJM Obinutuzumab, a humanized type II anti-CD20 monoclonal antibody, provided significantly better renal responses than placebo in a phase 2 trial involving patients with lupus nephritis receiving stan...

In the REGENCY trial, obinutuzumab, a humanized type II anti-CD20 monoclonal antibody, plus standard therapy provided significantly better renal responses than standard therapy alone in patients with lupus nephritis. Full trial results: nej.md/3Eq6gxV

#ISNWCN | @theisn.org

1 year ago 22 12 1 0
Advertisement
This is the front page of a fraudulent research article that purported to show a link between vaccines and autism. The word "RETRACTED" is written across it in large red letters. 

Wikipedia: On 28th February 1998, a fraudulent research paper by physician Andrew Wakefield and twelve coauthors, titled "Ileal-Lymphoid-Nodular Hyperplasia, Non-Specific Colitis, and Pervasive Developmental Disorder in Children", was published in the British medical journal The Lancet.[1] The paper falsely claimed causative links between the measles, mumps, and rubella (MMR) vaccine and colitis and between colitis and autism. The fraud involved data selection, data manipulation, and two undisclosed conflicts of interest.

This is the front page of a fraudulent research article that purported to show a link between vaccines and autism. The word "RETRACTED" is written across it in large red letters. Wikipedia: On 28th February 1998, a fraudulent research paper by physician Andrew Wakefield and twelve coauthors, titled "Ileal-Lymphoid-Nodular Hyperplasia, Non-Specific Colitis, and Pervasive Developmental Disorder in Children", was published in the British medical journal The Lancet.[1] The paper falsely claimed causative links between the measles, mumps, and rubella (MMR) vaccine and colitis and between colitis and autism. The fraud involved data selection, data manipulation, and two undisclosed conflicts of interest.

Today is Retraction Day, when we observe the anniversary of the retraction (Feb. 2, 2010) of the fraudulent paper that purported to show a link between vaccines and autism. 🧪#medsky

1 year ago 3983 1708 45 74
Preview
FDA approves Novo Nordisk's Ozempic to treat chronic kidney disease in those with diabetes, expanding its use Expanded Ozempic approval in the U.S. could transform how doctors treat patients with chronic kidney disease, which involves a gradual loss of kidney function.

BREAKING NEWS: The FDA has approved Ozempic for patients with chronic kidney disease. This means the popular injection can be used to reduce the risk of kidney disease worsening, kidney failure and death from cardiovascular disease in patients with chronic kidney disease and diabetes.

1 year ago 22 16 1 0
Post image

Nor am I!

1 year ago 45785 7991 826 495

Thx for clarifying. I guess I got overzealous in defending whichever of my colleagues (esp if fellow) you were debating with! 😭😛

1 year ago 1 0 1 0

Now, the contemporary true incidence of contrast AKI is likely very low owing to less nephrotoxic contrast(lower osmolality), lower volumes used, attention to care on whom to avoid if not necessary, more pervasive preventive protocols (IVF), etc etc.

1 year ago 0 0 0 0

Contrast-induced or associated AKI is absolutely real. Saying that it doesn’t exist means ur insulting generations of colleagues who came b4 us who observed/studied this phenomenon b4 our time and saying that it’s always been a fictitious entity in their minds.

1 year ago 1 0 2 0
Preview
a man in a black shirt says " don 't do this " in white letters ALT: a man in a black shirt says " don 't do this " in white letters

Infamous Phantom Nephro Recs:
1. Avoid nephrotoxins (pt needs atbxs + CTA)
2. Keep MAP >65 (on the floor, not on pressors)
3. Trend Cr daily (already ✔️BMPs q 8h happening)
4. Strict I/Os (on diapers, refuses Foley/PureWick)
5. Renally dose all meds (pt not on any renally cleared med)

1 year ago 46 12 2 2
Post image

An opposing view would be to throw caution to the wind and implement GDMT at a more accelerated rate similar to CHF

journals.lww.com/cjasn/fullte...

@asnkidney.bsky.social #CJASN
@brendonneuen.bsky.social

#NephJC

1 year ago 12 4 2 0
Advertisement
Post image

It has taken more than 4 years but the methodologically poor (doi.org/10.1016/j.th...) and questionable paper (1-day peer review bmcmedresmethodol.bi...) that promoted HCQ for COVID-19 is finally retracted. We've been saying for years it had to be (doi.org/10.1016/j.th...).

1 year ago 257 84 8 12

Furthermore corticosteroids increase cystatin C as well

1 year ago 1 0 0 0
Preview
Immunofluorescence Use and Techniques in Glomerular Diseases: A Review Abstract. Background: Immunofluorescence (IF) studies play an essential role in the evaluation of medical renal biopsies. Particularly, in the study of renal glomerular diseases, where it provides fun...

So very happy with this publication! I hope it will assist trainees in #nephrology and #renalpath in the uses of IF.

karger.com/gdz/article/...

1 year ago 12 7 0 0

Thank you @saynanorouzi.bsky.social for the invite and congrats on a phenomenal conference! #bluezone

1 year ago 3 1 1 0
Post image

Celebrating the holidays with @ucsfnephrology.bsky.social GN Club including several alumni of our fellowship GN track

1 year ago 11 1 0 0